Who makes [C-11]OMAR?

[C-11]OMAR is developed by Yale University.

Last reviewed 2026-04-20 · How we verify

[C-11]OMAR

Yale University · Phase 2 active Small molecule Quality 0/100

At a glance

Generic name	[C-11]OMAR
Sponsor	Yale University
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[C-11]OMAR CI brief — competitive landscape report
[C-11]OMAR updates RSS · CI watch RSS
Yale University portfolio CI